Announcement • May 06
IMCD N.V. to Report Q1, 2027 Results on Apr 29, 2027 IMCD N.V. announced that they will report Q1, 2027 results on Apr 29, 2027 Announcement • May 03
IMCD N.V. Approves Cash Dividend, Payable on 8 May 2026 IMCD N.V., at the AGM held on April 30, 2026 approved cash dividend of EUR 1.81 per share. Ex-dividend date is 5 May 2026. Dividend record date is 6 May 2026. Dividend payment date is 8 May 2026. Upcoming Dividend • Apr 28
Upcoming dividend of €1.81 per share Eligible shareholders must have bought the stock before 05 May 2026. Payment date: 08 May 2026. Payout ratio is a comfortable 49% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (2.5%). Valuation Update With 7 Day Price Move • Mar 26
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €83.50, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Trade Distributors industry in the United Kingdom. Total loss to shareholders of 41% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €161 per share. Announcement • Feb 21
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited on February 20, 2026. Through the integration of Willows Ingredients’ supplier partnerships, IMCD will broaden its portfolio and market access to customers throughout Ireland and the UK.
The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2026. Declared Dividend • Feb 20
Dividend reduced to €1.81 Dividend of €1.81 is 16% lower than last year. Ex-date: 5th May 2026 Payment date: 8th May 2026 Dividend yield will be 2.1%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (49% earnings payout ratio) and cash flows (35% cash payout ratio). The dividend has increased by an average of 25% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Feb 19
Full year 2025 earnings released: EPS: €3.69 (vs €4.86 in FY 2024) Full year 2025 results: EPS: €3.69 (down from €4.86 in FY 2024). Revenue: €4.81b (up 1.2% from FY 2024). Net income: €217.6m (down 22% from FY 2024). Profit margin: 4.5% (down from 5.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings. Announcement • Feb 18
IMCD N.V. Proposes Dividend for the Year 2025 IMCD N.V. proposed dividend of EUR 1.81 in cash per share (2024: EUR 2.15) for the year 2025. Valuation Update With 7 Day Price Move • Feb 10
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to €94.03, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Trade Distributors industry in the United Kingdom. Total loss to shareholders of 35% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €145 per share. Announcement • Dec 13
IMCD N.V. Announces Chief Financial Officer Changes IMCD N.V. announced that its Supervisory Board nominates Floris Lagerwerf to become Chief Financial Officer (CFO) of IMCD as of January 2027. Floris will succeed Hans Kooijmans, who has decided to retire as per the end of December 2026. Floris started his career as external auditor in 2006, and he joined IMCD in its Rotterdam headquarters in 2016 as Group Controller. In 2021 he became Finance & Operations Director at IMCD Switzerland, and since January 2023, serves as Vice-President Finance & Operations for the Americas region. As of January 1, 2026, Floris will be Vice-President Finance & Operations EMEA and Industrial Business Groups. Hans Kooijmans will remain CFO of IMCD until the end of 2026 and will support Floris towards the transition in 2027. Announcement • Oct 17
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp. on October 16, 2025. For the period ending December 31, 2024, Dong Yang FT Corp. reported total revenue of KRW 55.3 billion. The transaction is subject to customary (regulatory) closing conditions and is expected to close in the first quarter of 2026. Announcement • Aug 27
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa on August 27, 2025.
In 2024, Tillmanns reported annual revenues of ca. €143 million.
The transaction is subject to customary (regulatory) closing conditions and is expected to close in the fourth quarter of 2025.
Domenico Colella and Pietro Masi of Orsingher Ortu Avvocati Associati acted as legal advisor for IMCD N.V. (ENXTAM:IMCD). Ethica Holding S.p.A. acted as financial advisor for the shareholders of Tillmanns Spa. Massimo Di Terlizzi, Graziana Toscano, Giorgio Recine, and Costanza Ceruti of Studio Pirola Pennuto Zei & Associati acted as legal advisor for the shareholders of Tillmanns Spa. For strategic and tax matters, Tillmanns and its partner were supported by Stefano Cesati of Studio Pirola Pennuto Zei & Associati. Reported Earnings • Aug 01
First half 2025 earnings released: EPS: €2.20 (vs €2.48 in 1H 2024) First half 2025 results: EPS: €2.20 (down from €2.48 in 1H 2024). Revenue: €2.49b (up 3.9% from 1H 2024). Net income: €129.7m (down 8.2% from 1H 2024). Profit margin: 5.2% (down from 5.9% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Announcement • Jul 31
IMCD N.V., Annual General Meeting, Apr 30, 2026 IMCD N.V., Annual General Meeting, Apr 30, 2026. Announcement • Jun 30
IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA. IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA on June 30, 2025. The terms of the transaction are undisclosed.
For the period ending December 31, 2024, Apus Química SpA reported total revenue of approximately €15 million.
The transaction is subject to customary closing conditions and is expected to close in July 2025. Announcement • Jun 06
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa on June 6, 2025.
For the period ending December 31, 2024, Ferrer Alimentacion Sa reported total revenue of €112 million.
The transaction is subject to customary closing conditions and is expected to close in June 2025. Buy Or Sell Opportunity • May 20
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 15% to €125. The fair value is estimated to be €157, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has grown by 4.1%. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 7.7% per annum over the same time period. Upcoming Dividend • Apr 22
Upcoming dividend of €2.15 per share Eligible shareholders must have bought the stock before 29 April 2025. Payment date: 06 May 2025. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of British dividend payers (6.2%). Lower than average of industry peers (2.8%). Reported Earnings • Mar 07
Full year 2024 earnings released: EPS: €4.86 (vs €5.14 in FY 2023) Full year 2024 results: EPS: €4.86 (down from €5.14 in FY 2023). Revenue: €4.75b (up 6.4% from FY 2023). Net income: €278.2m (down 4.8% from FY 2023). Profit margin: 5.9% (down from 6.5% in FY 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has fallen by 1% per year. Announcement • Mar 06
IMCD N.V. announces Annual dividend, payable on May 06, 2025 IMCD N.V. announced Annual dividend of EUR 2.1500 per share payable on May 06, 2025, ex-date on April 29, 2025 and record date on April 30, 2025. New Risk • Dec 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks High level of debt (91% net debt to equity). Shareholders have been diluted in the past year (3.8% increase in shares outstanding). Buy Or Sell Opportunity • Nov 18
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 1.3% to €139. The fair value is estimated to be €175, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 14%. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 8.7% per annum over the same time period. Announcement • Nov 14
IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million. IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.
Security Name: Ordinary Shares
Security Type: Common Stock Announcement • Oct 17
IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group. IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Blumos Group on October 17, 2024.
The transaction is subject to customary regulatory closing conditions. The expected completion of the transaction is in the fourth quarter of 2024. Reported Earnings • Aug 04
First half 2024 earnings released: EPS: €2.48 (vs €2.68 in 1H 2023) First half 2024 results: EPS: €2.48 (down from €2.68 in 1H 2023). Revenue: €2.39b (up 4.2% from 1H 2023). Net income: €141.3m (down 7.5% from 1H 2023). Profit margin: 5.9% (down from 6.6% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Aug 03
IMCD N.V., Annual General Meeting, Apr 25, 2025 IMCD N.V., Annual General Meeting, Apr 25, 2025. Announcement • May 16
IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024 IMCD N.V. announced that at its AGM held on May 14, 2024, approved the dividend proposal of EUR 2.24 per share in cash. Ex-dividend date is on 16 May 2024. Dividend record date is on 17 May 2024. Dividend payment date is on 21 May 2024. Upcoming Dividend • May 09
Upcoming dividend of €2.24 per share Eligible shareholders must have bought the stock before 16 May 2024. Payment date: 21 May 2024. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (2.0%). Reported Earnings • Mar 04
Full year 2023 earnings released: EPS: €5.14 (vs €5.50 in FY 2022) Full year 2023 results: EPS: €5.14 (down from €5.50 in FY 2022). Revenue: €4.46b (down 3.4% from FY 2022). Net income: €292.3m (down 6.6% from FY 2022). Profit margin: 6.5% (down from 6.8% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 2.7% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. New Risk • Feb 28
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €693k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (76% net debt to equity). Significant insider selling over the past 3 months (€693k sold). Announcement • Jan 10
IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited. IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024. IMCD N.V. (ENXTAM:IMCD) will acquire the remaining 30% stake in Valuetree Ingredients Private Limited in 2025. The founders of Valuetree will continue to lead the company post-completion of this first tranche. For the financial year ended on March 31, 2023 Valuetree Ingredients Private Limited generated revenue of approximately INR 4.4 billion. IMCD N.V. (ENXTAM:IMCD) completed the acquisition of 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024. Announcement • Nov 30
IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board IMCD N.V. announced that Mrs. Dorthe Mikkelsen has been appointed as member of the Supervisory Board at the Extraordinary General Meeting of IMCD N.V. held on 27 November 2023. Buying Opportunity • Nov 17
Now 21% undervalued Over the last 90 days, the stock is up 9.5%. The fair value is estimated to be €171, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 35%. For the next 3 years, revenue is forecast to grow by 5.0% per annum. Earnings is also forecast to grow by 6.1% per annum over the same time period. Buying Opportunity • Aug 17
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 10%. The fair value is estimated to be €158, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 35%. For the next 3 years, revenue is forecast to grow by 4.9% per annum. Earnings is also forecast to grow by 7.2% per annum over the same time period. Reported Earnings • Aug 06
First half 2023 earnings released: EPS: €2.68 (vs €3.11 in 1H 2022) First half 2023 results: EPS: €2.68 (down from €3.11 in 1H 2022). Revenue: €2.30b (down 1.3% from 1H 2022). Net income: €152.7m (down 14% from 1H 2022). Profit margin: 6.6% (down from 7.6% in 1H 2022). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Announcement • Aug 02
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc. on August 1, 2023. Sachs Chemical, Inc. generated a revenue of approximately $50 million in 2022. IMCD welcomes Sachs’ 38 employees to its local organization. The closing of the transaction is subject to customary closing conditions and is expected to take place in August 2023. Announcement • Jun 17
IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group. IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group on June 16, 2023. IMCD will acquire Brylchem Pte Ltd, Chemipac Pte Ltd, and CMS Marketing Trading Co., Ltd. Brylchem Group achieved a revenue of approximately SGD 85 million in 2022. The transaction is expected to be completed in the fourth quarter of 2023, subject to customary closing conditions. Announcement • May 19
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. on May 19, 2023. In this transaction, IMCD will also acquire Euro Chemo-Pharma's wholly owned subsidiary, Biofresh Green Sdn Bhd. Euro Chemo-Pharma has reported revenue of approximately MYR 270 million during financial year ended on June 30, 2022. The closing of the transaction is subject to customary closing conditions. The transaction is expected to take place in the last quarter of 2023. Announcement • May 06
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd on May 5, 2023. KOI Products has generated a revenue of above €8 million in financial year 2022 and adds 13 employees to the IMCD Israel team. The closing of the transaction is subject to customary closing conditions and is expected to take place in June 2023. Upcoming Dividend • Apr 21
Upcoming dividend of €2.37 per share at 1.6% yield Eligible shareholders must have bought the stock before 28 April 2023. Payment date: 04 May 2023. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (2.1%). Reported Earnings • Feb 27
Full year 2022 earnings released: EPS: €5.50 (vs €3.64 in FY 2021) Full year 2022 results: EPS: €5.50 (up from €3.64 in FY 2021). Revenue: €4.62b (up 34% from FY 2021). Net income: €313.1m (up 51% from FY 2021). Profit margin: 6.8% (up from 6.0% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Trade Distributors industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Announcement • Feb 17
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd. IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd on February 16, 2023. CPS Oil-Tech generated a revenue of approximately ZAR 228 million in the financial year that ended on February 28, 2022. The company represents leading global suppliers and serves a large group of customers with an extensive portfolio of products alongside commercial and technical support. Joining forces with CPS Oil-Tech will enable IMCD South Africa to offer its customers an increased product offering, through the valued strategic principals that CPS Oil-Tech, already represents. The closing of the transaction is subject to customary closing conditions and regulatory approval and is expected to take place in the second quarter of 2023. Buying Opportunity • Oct 31
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be €163, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 31%. For the next 3 years, revenue is forecast to grow by 4.9% per annum. Earnings is also forecast to grow by 6.4% per annum over the same time period. Announcement • Oct 11
IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023 IMCD N.V. announced that they will report first half, 2023 results on Aug 04, 2023 Buying Opportunity • Oct 06
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 4.6%. The fair value is estimated to be €163, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 31%. For the next 3 years, revenue is forecast to grow by 4.9% per annum. Earnings is also forecast to grow by 6.4% per annum over the same time period. Buying Opportunity • Sep 15
Now 22% undervalued Over the last 90 days, the stock is up 1.2%. The fair value is estimated to be €162, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 31%. For the next 3 years, revenue is forecast to grow by 4.9% per annum. Earnings is also forecast to grow by 6.4% per annum over the same time period. Reported Earnings • Aug 05
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down €105.4m from profit in 1H 2021). Profit margin: (down from 6.2% in 1H 2021). The decrease in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 3.3%, compared to a 8.7% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Apr 27
Upcoming dividend of €1.62 per share Eligible shareholders must have bought the stock before 04 May 2022. Payment date: 09 May 2022. Payout ratio is a comfortable 45% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (4.6%). Lower than average of industry peers (1.8%). Valuation Update With 7 Day Price Move • Jan 10
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €162, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 21x in the Trade Distributors industry in the United Kingdom. Total returns to shareholders of 185% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €87.50 per share. Reported Earnings • Aug 05
First half 2021 earnings released: EPS €1.85 (vs €1.22 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €1.69b (up 19% from 1H 2020). Net income: €105.4m (up 64% from 1H 2020). Profit margin: 6.2% (up from 4.5% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. Executive Departure • Jun 29
Independent Member of Supervisory Board Michel G. Plantevin has left the company On the 24th of June, Michel G. Plantevin's tenure as Independent Member of Supervisory Board ended after 10.3 years in the role. We don't have any record of a personal shareholding under Michel G.'s name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 25.42 years. Upcoming Dividend • Jun 17
Upcoming dividend of €1.02 per share Eligible shareholders must have bought the stock before 24 June 2021. Payment date: 28 June 2021. Trailing yield: 0.8%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (1.2%). Is New 90 Day High Low • Mar 10
New 90-day high: €110 The company is up 6.0% from its price of €104 on 09 December 2020. The British market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Trade Distributors industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €57.76 per share. Reported Earnings • Mar 01
Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €2.79b (up 3.1% from FY 2019). Net income: €120.9m (up 12% from FY 2019). Profit margin: 4.3% (up from 4.0% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Analyst Estimate Surprise Post Earnings • Mar 01
Revenue beats expectations Revenue exceeded analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 9.6%, compared to a 3.9% growth forecast for the Trade Distributors industry in the United Kingdom. Is New 90 Day High Low • Jan 21
New 90-day high: €110 The company is up 6.0% from its price of €104 on 23 October 2020. The British market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Trade Distributors industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €69.05 per share. Is New 90 Day High Low • Nov 06
New 90-day high: €107 The company is up 19% from its price of €90.04 on 07 August 2020. The British market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Trade Distributors industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €69.36 per share. Is New 90 Day High Low • Oct 16
New 90-day high: €106 The company is up 19% from its price of €88.38 on 17 July 2020. The British market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Trade Distributors industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €75.21 per share.